Niche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping.

Over a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards.

Niche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada.

Niche built and coordinated the full communications strategy for this 20-institution European initiative, turning.

When stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche —.

From Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory.

Putting patients first, Niche supported ViiV Healthcare's global HIV outreach programmes with medical writing,.

At the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta.

For over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical.

A trusted writing partner to this Belfast-based early-phase CRO for over a decade, Niche turned BioKinetic Europe's.

Niche served as the English-language regulatory writing backbone for this Nordic consultancy, producing IBs, IMPDs and.